Yonghua ZHAO, Qian ZHANG, Zhenwei CHEN, Naiwei LIU, Chienchih KE, Youhua XU, Welkang WU

Simvastatin combined with bone marrow stromal cells treatment activatesastrocytes to ameliorate neurological function after ischemic stroke in rats

Evidence indicates that reactive astrocytes play an important role in neurological functional amelioration after stroke. Bone marrow stromal cell (BMSC) transplantation-promoted astrocyte-derived neurotrophic factors' expressions resulted in decreasing the number of apoptotic neurons and improving neurogenesis and angiogenesis in the ischemic boundary zone. Recent studies found that simvastatin had neuroprotective activity in acute stroke. However, it is still ambiguous as to whether simvastatin combined with BMSCs can further activate astrocytes, which contribute to neurological functional recovery after ischemic stroke. In our present study, we established a middle cerebral artery occlusion model in rats and found that combination treatment of simvastatin and BMSCs could significantly increase neurological functional scores and induce activated astrocytes to enhance stromal cell-derived factor-1 α, vascular endothelial growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor expressions compared with BMSC alone (P < 0.05) by immunofluorescence staining on the 7th day after ischemia. Furthermore, western blot results showed that combination treatment could notably activate the AKT/mammalian target of rapamycin signaling pathway in oxygen-glucose deprivation-induced astrocytes. It was superior to BMSC treatment at the 5-min time point (P < 0.01). Therefore, we think that combination treatment should be a more effective therapy after stroke due to synergic functions of supplementary approaches.

PDF

___

Argaw AT, Asp L, Zhang J, Navrazhina K, Pham T, Mariani JN, Mahase S, Dutta DJ, Seto J, Kramer EG et al (2012). Astrocytederived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. J Clin Invest 122: 2454–2468.
Barreto GE, Gonzalez J, Torres Y, Morales L (2011). Astrocyticneuronal crosstalk: implications for neuroprotection from brain injury. Neurosci Res 71: 107–113.
Béjot Y, Prigent-Tessier A, Cachia C, Giroud M, Mossiat C, Bertrand N, Garnier P, Marie C (2011). Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem Int 58: 102–111.
Campos-Martorell M, Salvador N, Monge M, Canals F, García- Bonilla L, Hernández-Guillamon M, Ayuso MI, Chacón P, Rosell A, Alcazar A et al (2014). Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model. J Neurochem 130: 301–312.
Chen J, Cui X, Zacharek A, Chopp M (2009). Increasing Ang1/ Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med 13: 1348–1357.
Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M (2001). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005–1011.
Chen Y, Ai Y, Slevin JR, Maley BE, Gash DM (2005). Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor. Exp Neurol 196: 87–95.
Cui X, Chopp M, Zacharek A, Roberts C, Lu M, Savant-Bhonsale S, Chen J (2009). Chemokine, vascular and therapeutic effects of combination Simvastatin and BMSC treatment of stroke. Neurobiol Dis 36: 35–41.
Gao Q, Li Y, Chopp M (2005). Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult. Neuroscience 136: 123–134.
Garcia JH, Wagner S, Liu KF, Hu XJ (1995). Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke 26: 627– 634.
Jang H, Oh MY, Kim YJ, Choi IY, Yang HS, Ryu WS, Lee SH, Yoon BW (2014). Hydrogen sulfide treatment induces angiogenesis after cerebral ischemia. J Neurosci Res 92: 1520–1528.
Jin R, Zhu X, Liu L, Nanda A, Granger DN, Li G (2013). Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice. Stroke 44: 1135–1143.
Kowiański P, Lietzau G, Steliga A, Waśkow M, Moryś J (2013). The astrocytic contribution to neurovascular coupling-still more questions than answers? Neurosci Res 75: 171–183.
Kuric E, Wieloch T, Ruscher K (2013). Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke. Exp Neurol 247: 202–208.
Li L, Lundkvist A, Andersson D, Wilhelmsson U, Nagai N, Pardo AC, Nodin C, Ståhlberg A, Aprico K, Larsson K et al (2008). Protective role of reactive astrocytes in brain ischemia. J Cereb Blood Flow Metab 28: 468–481.
Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N et al (2002). Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59: 514–523.
Longa EZ, Weinstein PR, Carlson S, Cummins R (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84–91.
Lu DY, Tang CH, Yeh WL, Wong KL, Lin CP, Chen YH, Lai CH, Chen YF, Leung YM, Fu WM (2009). SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NFkappaB- dependent pathway in microglia. Eur J Pharmacol 613: 146–154.
Lui NP, Chen LW, Yung WH, Chan YS, Yung KK (2012). Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism. PLoS One 7: e51294.
Mele T, Jurič DM (2014). Metrifonate, like acetylcholine, up-regulates neurotrophic activity of cultured rat astrocytes. Pharmacol Rep 66: 618–623.
Miyazaki H, Nagashima K, Okuma Y, Nomura Y (2001). Expression of glial cell line-derived neurotrophic factor induced by transient forebrain ischemia in rats. Brain Res 922: 165–172.
Pastor MD, García-Yébenes I, Fradejas N, Pérez-Ortiz JM, Mora- Lee S, Tranque P, Moro MA, Pende M, Calvo S (2009). mTOR/ S6 kinase pathway contributes to astrocyte survival during ischemia. J Biol Chem 284: 22067–22078.
Pekny M, Pekna M (2004). Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204: 428–437.
Pirzad Jahromi G, Seidi S, Sadr SS, Shabanzadeh AP, Keshavarz M, Kaka GR, Hosseini SK, Sohanaki H, Charish J (2012). Therapeutic effects of a combinatorial treatment of simvastatin and bone marrow stromal cells on experimental embolic stroke. Basic Clin Pharmacol Toxicol 110: 487–493.
Shang YC, Chong ZZ, Wang S, Maiese K (2011). Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia. Curr Neurovasc Res 8: 270–285.
Shen LH, Li Y, Chopp M (2010). Astrocytic endogenous glial cell derived neurotrophic factor production is enhanced by bone marrow stromal cell transplantation in the ischemic boundary zone after stroke in adult rats. Glia 58: 1074–1081.
Shin JH, Park YM, Kim DH, Moon GJ, Bang OY, Ohn T, Kim HH (2014). Ischemic brain extract increases SDF-1 expression in astrocytes through the CXCR2/miR-223/miR-27b pathway. Biochim Biophys Acta 1839: 826–836.
Sofroniew MV, Vinters HV (2010). Astrocytes: biology and pathology. Acta Neuropathol 119: 7–35.
Sun YY, Lin SH, Lin HC, Hung CC, Wang CY, Lin YC, Hung KS, Lien CC, Kuan CY, Lee YH (2013). Cell type-specific dependency on the PI3K/Akt signaling pathway for the endogenous Epo and VEGF induction by baicalein in neurons versus astrocytes. PLoS One 8: e69019.
Swanson RA, Ying W, Kauppinen TM (2004). Astrocyte influences on ischemic neuronal death. Curr Mol Med 4: 193–205.
Szydlowska K, Gozdz A, Dabrowski M, Zawadzka M, Kaminska B (2010). Prolonged activation of ERK triggers glutamateinduced apoptosis of astrocytes: neuroprotective effect of FK506. J Neurochem 113: 904–918.
Wang M, Zou Z (2014). Multiple mechanisms of SDF-1 promoting VEGF-induced endothelial differentiation of mesenchymal stem cells. Int J Cardiol 177: 1098–1099.
Wei L, Fraser JL, Lu ZY, Hu X, Yu SP (2012). Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 46: 635–645.
Wu X, Kihara T, Akaike A, Niidome T, Sugimoto H (2010). PI3K/ Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes. Biochem Biophys Res Commun 393: 514–518.
Xu J, Liu X, Chen J, Zacharek A, Cui X, Savant-Bhonsale S, Liu Z, Chopp M (2009). Simvastatin enhances bone marrow stromal cell differentiation into endothelial cells via notch signaling pathway. Am J Physiol Cell Physiol 296: C535–543.
Xu Q, Wang S, Jiang X, Zhao Y, Gao M, Zhang Y, Wang X, Tano K, Kanehara M, Zhang W et al (2007). Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor- 1α and monocyte chemoattractant protein-1 upregulation in vitro. Clin Exp Pharmacol Physiol 34: 624–631.
Yilmaz G, Arumugam TV, Stokes KY, Granger DN (2006). Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113: 2105–2112.
Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M (2007). Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cereb Blood Flow Metab 27: 1684– 1691.
Zacharek A, Chen J, Cui X, Yang Y, Chopp M (2009). Simvastatin increases notch signaling activity and promotes arteriogenesis after stroke. Stroke 40: 254–260.
Zhao Y, Lai W, Xu Y, Li L, Chen Z, Wu W (2013). Exogenous and endogenous therapeutic effects of combination Sodium Ferulate and bone marrow stromal cells (BMSCs) treatment enhance neurogenesis after rat focal cerebral ischemia. Metab Brain Dis 28: 655–666.
Zhou B, Han ZC, Poon MC, Pu W (2007). Mesenchymal stem/ stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses 68: 1268– 1271.
Zhu MX, Lu C, Xia CM, Qiao ZW, Zhu DN (2014). Simvastatin pretreatment protects cerebrum from neuronal injury by decreasing the expressions of phosphor-CaMK II and AQP4 in ischemic stroke rats. J Mol Neurosci 54: 591–601.